NRG
GDRX icon

Nemes Rush Group’s GoodRx Holdings GDRX Stock Holding History

Nemes Rush Group’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-238
Closed -$1.69K – 755
2024
Q3 		$1.69K Hold
238
– – ﹤0.01% 524
2024
Q2 		$1.86K Hold
238
– – ﹤0.01% 522
2024
Q1 		$1.69K Hold
238
– – ﹤0.01% 578
2023
Q4 		$1.59K Hold
238
– – ﹤0.01% 568
2023
Q3 		$1.34K Sell
238
-4,133
-95% -$27.6K ﹤0.01% 567
2023
Q2 		$24.1K Buy
+4,371
New +$23.5K ﹤0.01% 343

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nemes Rush Group's GDRX Position: Q4 2024 in Review

Nemes Rush Group sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 238 shares — an estimated $1.69K sold.

Nemes Rush Group first reported a position in GDRX in Q2 2023 and held it in 6 quarters. The position peaked at $24.1K in Q2 2023. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • Nemes Rush Group reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
  • Nemes Rush Group sold 238 GoodRx Holdings shares in Q4 2024, an estimated $1.69K.
  • Nemes Rush Group first reported a position in GoodRx Holdings in Q2 2023 and held it in 6 quarters.
  • Nemes Rush Group's GoodRx Holdings position peaked at $24.1K in Q2 2023.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Nemes Rush Group's 13F filing for Q4 2024, filed 12 Feb 2025.